DM1, Effects of Carbo-Counting on Glycemic Control
Effectiveness of Carbohydrate Counting on Glycaemic Control in T1DM Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Emanuela Orsi, MD
- Phone Number: 0255034590
- Email: emanuela_orsi@yahoo.it
Study Contact Backup
- Name: valeria grancini, MD
- Phone Number: 0039 3926233299
- Email: valeria_grancini@hotmail.it
Study Locations
-
-
-
Milan, Italy, 20133
- Recruiting
- Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico
-
Contact:
- Valeria Grancini, MD
- Phone Number: 00393926233299
- Email: valeria_grancini@hotmail.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- type 1 diabetes mellitus
- insulin therapy
- HbA1c from 5.5 to 10%
Exclusion Criteria:
- pregnancy
- celiac disease
- hepatic impairment
- chronic renal failure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: carbo-counters
carbohydrate counting: patients attending a structured carbohydrate-counting training and practicing this tecnique to manage insulin therapy
|
patients will attend a 5 meetings-structured training to learn how to manage their insulin therapy depending on the amount of carbohydrates contained in foods
|
|
Active Comparator: control group
insulin therapy according to standard care.
patients who don't practice carbohydrate-counting to manage insulin therapy
|
patients will not manage their insulin therapy depending on the amount of carbohydrates contained in foods, but will follow a fix basal bolus scheme
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
glycemic control
Time Frame: 2 years
|
HbA1c
|
2 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anthropometric parameters: BMI
Time Frame: 2 years
|
variations in body mass index (BMI: units kg/m2), weight and height will be combined to report BMI in kg/m^2
|
2 years
|
|
anthropometric parameters: WAIST AND HIP CIRCUMFERENCE
Time Frame: 2 years
|
variations in waist and hip circumference (units: cm)
|
2 years
|
|
anthropometric parameters: BIOIMPEDENTIOMETRIC PARAMETERS
Time Frame: 2 years
|
fat mass and free fat mass (units: % of total mass)
|
2 years
|
|
dietary lifestyle
Time Frame: 2 years
|
variations in intake of simple sugars, animal protein rich foods, saturated fats and cholesterol, UDM: grams/die.
All the informations will be collected using 5days food diaries, completed by the patients.
|
2 years
|
|
glucose variability: mean and standard deviation of self monitoring blood glucose (SMBG)
Time Frame: 2 YEARS
|
mean and standard deviation of self monitoring blood glucose (SMBG), data collected from glucometers, units: mg/dl
|
2 YEARS
|
|
glucose variability: incidence of hypoglycaemia
Time Frame: 2 YEARS
|
incidence of hypoglycaemia (SMBG < 70 mg/dl), units: n° episodes/week
|
2 YEARS
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Emanuela Orsi, FOndazione IRCCS Ca' Granda Opedale Maggiore Policlinico Milano
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DM1cc
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.